149 related articles for article (PubMed ID: 21951753)
21. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
23. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
Gahimer J; Wernicke J; Yalcin I; Ossanna MJ; Wulster-Radcliffe M; Viktrup L
Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
25. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
[TBL] [Abstract][Full Text] [Related]
26. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
[TBL] [Abstract][Full Text] [Related]
27. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
29. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
Ziegler D; Schneider E; Boess FG; Berggren L; Birklein F
J Diabetes Complications; 2014; 28(5):698-704. PubMed ID: 24862108
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
Gao Y; Ning G; Jia WP; Zhou ZG; Xu ZR; Liu ZM; Liu C; Ma JH; Li Q; Cheng LL; Wen CY; Zhang SY; Zhang Q; Desaiah D; Skljarevski V
Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
[TBL] [Abstract][Full Text] [Related]
31. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
[TBL] [Abstract][Full Text] [Related]
32. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
Sun P; Zhao Y; Zhao Z; Watson P
Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
[TBL] [Abstract][Full Text] [Related]
33. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Hall JA; Wang F; Oakes TM; Utterback BG; Crucitti A; Acharya N
Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
[TBL] [Abstract][Full Text] [Related]
35. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
36. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
37. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall JA; Risser RC; Gonzales JS
Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
[TBL] [Abstract][Full Text] [Related]
38. Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.
Liu X; Cui Z; Niu L; Faries DE; Ball T; Johnstone B
Clin Ther; 2011 Nov; 33(11):1726-38. PubMed ID: 22019345
[TBL] [Abstract][Full Text] [Related]
39. Safety profile of treatment in diabetic peripheral neuropathic pain.
Robinson-Papp J; Simpson DM
Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
[TBL] [Abstract][Full Text] [Related]
40. Diabetic peripheral neuropathic pain: recognition and management.
Cole BE
Pain Med; 2007 Sep; 8 Suppl 2():S27-32. PubMed ID: 17714113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]